Your session is about to expire
← Back to Search
Cognitive Processing Therapy for PTSD-BPD
N/A
Recruiting
Led By Candice M Monson, PhD
Research Sponsored by Palo Alto University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Current DSM-5 diagnosis of PTSD and BPD
Aged 18-65 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-weeks, post-treatment/6-weeks, 3-month follow-up
Awards & highlights
Study Summary
This trial will study whether a brief, 12-session treatment for PTSD-BPD, delivered via telehealth, is more effective than usual treatment + suicide risk management, in terms of reducing symptoms of both disorders.
Who is the study for?
This trial is for adults aged 18-65 in the Bay Area with PTSD and BPD who are willing to be recorded during sessions. It's not for those with severe comprehension issues, EU residents, life-threatening illnesses, acute mania or psychosis, or intellectual disabilities.Check my eligibility
What is being tested?
The study tests Cognitive Processing Therapy enhanced with Suicide Risk Management (CPT+SRM) against usual treatment plus SRM. Conducted via telehealth over 12 sessions, it aims to improve PTSD-BPD symptoms by targeting emotional intensity and cognitive dysfunction.See study design
What are the potential side effects?
Participants may experience emotional distress or discomfort when discussing trauma and mental health issues. There's also a risk of increased suicidality or self-harm which will be managed through a suicide risk protocol.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with PTSD and BPD.
Select...
I am between 18 and 65 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-weeks, post-treatment/6-weeks, 3-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-weeks, post-treatment/6-weeks, 3-month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Borderline Symptom List 23 (BSL-23) [SELF-REPORT]
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Secondary outcome measures
A Demographic Form [SELF-REPORT]
Acceptability of Intervention Measure (AIM)
Beck's Depression Inventory-II (BDI-II) [SELF-REPORT]
+24 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: TAU + SRMExperimental Treatment1 Intervention
Participants will be randomized to teletherapy sessions with only Suicide Risk Management for PTSD-BPD which will be administered once a week for 6 weeks, for a total of 6 sessions.
Group II: CPT + SRMExperimental Treatment1 Intervention
Participants will be randomized to teletherapy sessions of Cognitive Processing Therapy + Suicide Risk Management for PTSD-BPD which will be administered twice weekly over 6 weeks, for a total of 12 sessions.
Find a Location
Who is running the clinical trial?
Toronto Metropolitan UniversityOTHER
84 Previous Clinical Trials
10,934 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
42 Patients Enrolled for Borderline Personality Disorder
York UniversityOTHER
58 Previous Clinical Trials
17,443 Total Patients Enrolled
2 Trials studying Borderline Personality Disorder
102 Patients Enrolled for Borderline Personality Disorder
Stanford UniversityOTHER
2,395 Previous Clinical Trials
17,341,317 Total Patients Enrolled
2 Trials studying Borderline Personality Disorder
75 Patients Enrolled for Borderline Personality Disorder
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: TAU + SRM
- Group 2: CPT + SRM
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings in this research endeavor for participants?
"As noted on clinicaltrials.gov, this medical trial is not currently enrolling new patients; the posting was first uploaded on June 30th 2022 and last updated 15 days later. However, there are 1267 alternative trials actively seeking participants at this time."
Answered by AI
What population is most advantageous to recruit for this scientific experiment?
"This medical study seeks 33 volunteers, aged 18-65 years old and suffering from borderline personality disorder. To be eligible for this trial, patients must live in the Bay Area with a DSM-5 diagnosis of PTSD and BPD as well as consent to audio or video recordings during assessment and treatment sessions."
Answered by AI
Does this trial embrace individuals beyond the age of fifty?
"The lower limit for participation in this clinical trial is 18 years of age and the upper boundary is 65."
Answered by AI
Who else is applying?
What state do they live in?
Pennsylvania
Ohio
California
Other
How old are they?
18 - 65
What site did they apply to?
Candice M. Monson
Palo Alto University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
2
3+
Why did patients apply to this trial?
Looking for ANY help I can get! Relief from depression, stress and MCI. Because nothing has worked for my bpd and suicidal thoughts.
PatientReceived 1 prior treatment
I’ve tried many therapies and medications and want to try other options and learn more about my BPD.
PatientReceived 2+ prior treatments
What questions have other patients asked about this trial?
What does it entail? Do I need to have insurance?
PatientReceived 2+ prior treatments
How responsive is this trial?
Most responsive sites:
- Candice M. Monson: < 48 hours
- Palo Alto University: < 48 hours
Average response time
- < 2 Days
Typically responds via
Email
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger